Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results - CNNMoney.com (press release) PDF Print
CNNMoney.com (press release)Zerenex has recently completed a Phase 2 clinical program as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.